Most software comparison articles in this space are written by the vendors selling the software. That’s not what this is.
If you’re a clinic director or lab manager in Europe evaluating a new practice management system, you’re not short on demos. You’re short on a way to compare them that isn’t just a features list dressed up as “insight.” So here’s a checklist built around the questions that actually separate a good fit from an expensive mistake, most of which never come up until month three of implementation.
1. Does it actually understand European regulatory requirements, or is compliance bolted on?
This is the first filter, and it should eliminate more vendors than you’d expect.
- GDPR isn’t optional, and it isn’t generic. Ask specifically how patient and embryo data is stored, where servers are physically located, and what happens to data if you switch providers later. “We’re GDPR compliant” is a marketing sentence. Data residency, retention policies, and breach notification procedures are the actual answer.
- EU SoHO Regulation. The updated Substances of Human Origin regulation directly affects how reproductive tissue and cell data must be traced and reported. If a vendor can’t explain how their system handles SoHO traceability requirements without pausing to check with engineering, that’s a signal, this should be a designed-in feature, not a future roadmap item.
- Cross-border data transfer, relevant if your clinic treats patients from outside the EU or shares data with partner labs abroad.
2. Can it talk to your embryology lab equipment, or does it just claim to?
This is where the gap between marketing copy and reality shows up fastest.
Ask for a live demonstration, not a slide, of the integration with your time-lapse incubation system (EmbryoScope or equivalent). Then ask the pointed question: is this a background sync, or does it require someone to manually trigger data retrieval?
Neither answer is automatically wrong, but you need to know which one you’re getting, because it changes your embryologists’ daily workflow. Choose based on how your lab actually works, not on which option sounds more “advanced” in a sales pitch.
3. How does it handle the AI features it’s advertising?
Almost every vendor now has an AI story. Fewer have a good answer when you ask:
- What is the AI model actually trained on, and is that data representative of your patient population?
- Is the AI feature assistive (flagging patterns for embryologist review) or is it making unsupervised recommendations?
- Can you turn it off, and does the software still function fully without it?
If a vendor can’t clearly separate “what the AI suggests” from “what the embryologist decides,” treat that as a governance red flag, not a feature.
4. What does implementation actually cost, in time, not just money?
The license fee is rarely where clinics get surprised. The real costs are:
- Migration. How much of your existing patient history, cycle data, and lab records can be migrated automatically versus manually re-entered?
- Training time. How many hours per staff role, realistically, before the team is at full speed? Ask for a reference clinic of similar size you can actually call.
- Parallel running. Will you need to run old and new systems simultaneously during transition, and for how long? This is often the single most disruptive and understated cost of switching systems.
5. Who owns the relationship after the contract is signed?
A checklist item that’s easy to skip and expensive to ignore.
- Is support based in a time zone that overlaps with your clinical hours?
- Is there a dedicated point of contact, or a ticket queue?
- What’s the actual SLA for a system-down incident during an active cycle, not the SLA in the contract’s fine print, but what clinics report happens in practice?
6. Does the roadmap match where the field is actually going, or where it was five years ago?
Ask vendors directly what they’re building next, and why. European fertility clinics are under real pressure from multiple directions at once: SoHO compliance deadlines, patient demand for transparency, staffing shortages in embryology, and rising expectations around AI-assisted lab work. A vendor whose roadmap doesn’t reference at least the first two isn’t paying attention to your regulatory reality.
The bottom line
None of this is about finding the vendor with the longest features list. It’s about finding the one whose honest answers to these six questions match how your clinic actually operates — not how a demo makes it look for forty-five minutes.
If a vendor won’t answer some version of these questions directly, in writing, before you sign anything, that’s information too.
